Animal Science

Based upon HS Pharmaceuticals’ silicate-based nanoparticle technology, licensees of the HSX technology are developing ointments to help aid wound healing and possibly tumor reduction for the companion-pet and equine markets. These variations of the technology are anticipated to move into United States manufacturing and sales in Q3 2017, with European Union manufacturing and sales by…